Denghui Chen received an F31 Predoctoral Individual National Research Service Award from the NIH & NIDA for his project titled “Unraveling the Role of Tandem Repeats and Structural Variants in Addiction-Related Behaviors Using Heterogeneous Stock Rats.”
Dr. Zachary Tatom has been selected to receive a two year postdoctoral slot on the National Institute on Alcohol Abuse and Alcoholism (NIAAA) T32 for fall 2025, with Dr. Palmer as his mentor. Under the fellowship, Zachary will engage in alcohol research and studies within Palmer Lab with T32 support for up to two years.
Congratulations, Zachary!
A new R01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Sandra Sanchez-Roige, with Dr. Abraham Palmer as co-investigator.
The 5-year grant is titled “Multi-ancestry, multivariate genome-wide association analysis of opioid-related traits in half a million individuals” and it will start January 15, 2025 and end on November 30, 2029.
Congratulations!
The NIDA Core Center of Excellence grant titled, “Center for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats,” has been awarded to Drs. Abraham Palmer, Pejman Mohammadi, Oksana Polesskaya, and Leah Solberg Woods.
Congratulations!
A competitive renewal of the U01 grant “Genetics of novelty seeking and propensity for drug abuse in outbred rats” was awarded to Drs. Huda Akil, Jun Li, and Stanley Watson. Dr. Palmer is Co-I and PI of the subcontract to UC San Diego.
A new R01 grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) was awarded to Dr. Giordano de Guglielmo, with Dr. Abraham Palmer as co-investigator. The 5-year grant is titled “Identification of Genetic Variants that Influence Compulsive Alcohol Intake in Outbred Rats” and will start March 10, 2023 and end on February 29, 2028.
A new R01 grant titled, “A Framework for Translating Polygenic Findings Related to Alcohol Use Disorder Across Species”, has been awarded to Dr. Abraham Palmer as the Project Director. This 5 year grant incudes more than $2.7M starting September 16th, 2022 and ends on August 31st, 2027.
Congrats, Dr. Palmer!
The new NIDA U01 Grant, “Identification of Genetic Variants that Contribute to Compulsive Cocaine Intake in Rats”, has been awarded to Dr. Abraham Palmer and Dr. Olivier George. This grant will fund the behavioral characterization, biobanking, genotyping and GWAS analysis of 2,082 rats over 5 years. The first milestone for this grant is to implement raspberry pi monitoring systems into Dr. George’s machine-learning data pipeline.
Congratulations!
The grant titled, “Integrative Omics Center for Accelerating Neurobiological Understanding of Opioid Addiction”, has been awarded to Drs. Eric Otto Johnson, Abraham Palmer and several others. The goal of the Integrative Omics Center for Accelerating Neurobiological Understanding of Opioid Addiction (ICAN) is to identify the genetic basis for opioid addiction. Dr. Palmer is an MPI for project 3, which seeks to integrate rodent and human studies using statistical genetic approaches and rodent experiments.
Congratulations!
The grant, “Computational methods for allele-specific expression quantification”, was awarded to Dr. Seyoung Kim and Dr. Abraham Palmer. This grant is supported by the Carnegie Mellon University/National Science Foundation.
The major goals of this grant are to develop computational methodology to quantify allele-specific expression from RNA-seq and genotype data to apply to intercross mouse data.
Congratulations!
